Cardiac Surveillance by Syndrome

Syndrome

At a glance: main interval

SyndromeIntervalSource
22q11.2 deletionEcho and ECG at diagnosis. Any CHD: long-term follow-up, listed as “annual/biennial”. All from 1 y, with or without CHD: periodic arrhythmia, ECG and aortic root screening; no interval stated.Óskarsdóttir 2023 Table 1
22q11.2 deletion AdultEcho at first assessment if none as an adult or in recent years; cardiovascular assessment every 1–2 y. Any CHD: regular follow-up at an adult CHD center.Boot 2023 Table 1, text
WilliamsCardiology, 3-limb BP and echo every 3 mo to 1 y, yearly to 5 y, then every 2 y (Table 3; its text: at least annually through middle childhood). ECG yearly. Sedation and anesthesia: raised risk.AAP 2020 Table 3, text
DownNewborn echo. Cardiac lesions: cardiology follow-up, even after repair; from 5 y individualized by cardiac history, no interval stated. 12–21 y or older: yearly exam for acquired valve disease. Pulmonary hypertension: raised risk even without a defect.AAP 2022
NoonanEcho and ECG at diagnosis; if normal, cardiology every 5 y. On GH: echo about every 6 mo, citing a review.AHA 2018; Kawai 2026 CQ8
CostelloUrgent cardiology at diagnosis. No known disease: to 2 y, ECG every 3–6 mo and echo every 6 mo; then echo and ECG every 2–3 y to 20 y, every 1–2 y as an adult. Known disease: by type and severity. On GH: every 6 mo for the first year.Gripp 2019 Table 1, text
CFCEcho and ECG at diagnosis. No cardiac disease: echo every 2–3 y to 20 y, every 3–5 y as an adult. Cardiac disease: the cardiologist sets the frequency.Pierpont 2014 Table 1, text
TurnerTTE at diagnosis, at 9–11 y, after growth or at transition; adults at least every 5–10 y. BP yearly. Dilated aorta or BAV, HTN, CoA: shorter, by Z under 15 y and by ASI, AHI or Z over 15 y; guidelines differ at ASI ≥2.3.Gravholt 2024 R 4.7, R 4.8, R 4.17, Figures 4–5
Marfan, Loeys-Dietz, vascular EDSAdult intervals and the pediatric approach on Aortopathy.See that page
Holt-OramECG yearly.AHA 2018
JacobsenEcho at baseline and as needed.AHA 2018
Tuberous sclerosisAsymptomatic child: echo every 1–3 y until rhabdomyomas regress. Asymptomatic, all ages: ECG at least every 3–5 y.Northrup 2021 Table 4, text
NF1BP at least yearly. Murmur or NF1 microdeletion: cardiology and echo.AAP 2019
PHACEScreening echo; yearly echo with a nonobstructive arch anomaly.Garzon 2016
Cornelia de LangeEcho in every diagnosed infant and child; no interval.Kline 2018
Rubinstein-TaybiCardiac sonography at diagnosis; no interval.Lacombe 2024

Tap a syndrome name or chip for every row, with age, strength and source.

22q11.2 deletion syndrome

Consensus, not formally graded (Óskarsdóttir 2023, 22q11.2 Society). Adult rows: not graded, and the authors say to treat all their recommendations as weak, meaning conditional or individualized (Boot 2023).

Age or groupWhat and how oftenSource
At diagnosisEcho and ECG; determine arch sidedness.Óskarsdóttir 2023 Table 1
To 18 yAny CHD: long-term follow-up, listed as “annual/biennial” and in every age band; transition to grown-up congenital heart (GUCH) care.Óskarsdóttir 2023 Table 1
1–18 yAll, with or without CHD: periodic screening for arrhythmia, ECG abnormalities and dilated aortic root. No interval stated.Óskarsdóttir 2023 Table 1, footnote d
To 18 yAt risk: antiepileptic or neuropsychiatric drugs, hypocalcemia, thyroid disease. Periodic ECG, listed as “annual/biennial”.Óskarsdóttir 2023 Table 1
AdultEcho at first assessment if not done as an adult or in recent years; low threshold for aortic root dilation.Boot 2023 Table 1
AdultEvery 1–2 y: blood pressure, resting heart rate; congenital cardiac (ACHD) and cardiovascular risk assessment.Boot 2023 Table 1
AdultAny CHD: regular follow-up at an adult CHD center. No interval stated.Boot 2023 text
AdultNo CHD history: periodic assessment for aortic root dilation, risk factors and hypertension. No interval stated.Boot 2023 text
Williams syndrome

AAP 2020 clinical report; not graded. AAP reports expire at 5 years unless reaffirmed (2025 here); no reaffirmation found.

Age or groupWhat and how oftenSource
At diagnosisPediatric cardiologist: 3-limb BP (2 arms, 1 leg), echo with Doppler, ECG.AAP 2020 Table 3
0–12 moCardiology with 3-limb BP and echo: every 3 mo.AAP 2020 Table 3
1–5 yCardiology with 3-limb BP and echo: yearly.AAP 2020 Table 3
6–18 yCardiology with 3-limb BP and echo: every 2 y in Table 3. Its text differs: at least annually through middle childhood, then by the nature and severity of disease.AAP 2020 Table 3, text
AdultCardiology with 3-limb BP and echo: every 2 y.AAP 2020 Table 3
All agesECG yearly.AAP 2020 Table 3
All agesBP in both arms, murmurs, bruits and pulses each visit. Consider cardiology or nephrology referral for BP >90th percentile for age and height.AAP 2020 Table 3, text
Any ageTable 3: consider CT, MRA or catheterization with severe SVAS, diminished femoral pulses, bruits or suspected long-segment aortic stenosis. Text: decreased pulses, bruits or diffuse thoracic aortic stenosis will require further imaging.AAP 2020 Table 3, text
Any ageSedation and anesthesia: raised risk of myocardial ischemia, acute hemodynamic deterioration and sudden death, greatest with biventricular outflow tract obstruction. Pediatric anesthesia consultation before procedures (Table 3, to 18 y); plan procedures, particularly nonemergency ones, with pediatric anesthesiologists who know Williams syndrome, in a center with multidisciplinary support for cardiac decompensation.AAP 2020 Table 3, text
Down syndrome (trisomy 21)

AAP 2022 clinical report, AHA 2024 statement; not graded.

Age or groupWhat and how oftenSource
Birth–1 moEcho read by a pediatric cardiologist, whatever the fetal echo showed. Abnormal: refer to pediatric cardiology.AAP 2022, Birth to 1 Month; AHA 2024
1 mo–1 yInfants with cardiac defects: watch for heart failure at every well-child visit as pulmonary vascular resistance falls.AAP 2022, 1 Month to 1 Year
1–5 yCardiac lesions: keep pediatric cardiology follow-up, even after complete repair, for residual lesions and pulmonary hypertension.AAP 2022, 1 to 5 Years
5–12 yIndividualize cardiology follow-up by cardiac history. No interval stated.AAP 2022, 5 to 12 Years
12–21 y or olderExamine yearly for acquired mitral and aortic valve disease. Echo for increasing fatigue, shortness of breath, exertional dyspnea, or a new murmur or gallop. Individualize cardiology follow-up by cardiac history; no interval stated.AAP 2022, 12 to 21 Years or Older
Infant, childPulmonary hypertension: raised risk even without a structural heart defect (AAP 2022). No national screening recommendation specific to children with trisomy 21 (AHA 2024).AAP 2022, 1 Month to 1 Year; AHA 2024
Noonan syndrome

AHA 2018 rows are written for RASopathies as a group; Kawai 2026 rows are Noonan only (Japanese societies). Costello, CFC: use their own panels.

Age or groupWhat and how oftenStrengthSource
At diagnosisCardiologist with echo and ECG.Not gradedAHA 2018, Suggested Cardiac Follow-up
All agesNo cardiac disease: repeat evaluation every 5 y through childhood and adulthood.Not gradedAHA 2018, Suggested Cardiac Follow-up
All agesCardiac disease: follow-up tailored to the findings.Not gradedAHA 2018, Suggested Cardiac Follow-up
ChildNoonan, initial assessment: chest radiograph, 12-lead ECG and TTE. No interval stated.Strong, level BKawai 2026 CQ4
AdultNoonan: lifelong follow-up; every 3–6 mo to every few years by pathology and severity.No grade on this sentenceKawai 2026 text under CQ4
On GHNoonan, question on HCM: regular TTE follow-up. Evidence text: about every 6 mo, citing a review.Weak, level C; no grade on the intervalKawai 2026 CQ8
Costello syndrome

Gripp 2019; not graded.

Age or groupWhat and how oftenSource
At diagnosisUrgent pediatric cardiology: echo, ECG, Holter.Gripp 2019 Table 1, text
0–2 yNo known disease: cardiologist with ECG every 3–6 mo; echo every 6 mo; Holter for tachycardia or irregular rhythm.Gripp 2019 Table 1
2–20 yNo known disease: cardiologist with echo and ECG every 2–3 y; Holter if concern for tachycardia; baseline fasting lipids at 9–11 y; BP at routine visits.Gripp 2019 Table 1
Adult, >20 yNo known disease: cardiologist with echo and ECG every 1–2 y; lipids every 3–5 y; BP at routine visits. Consider coronary CTA; CTA or MRA if echo suggests aortic dilation.Gripp 2019 Table 1
All agesKnown disease: by type and severity. Apparently resolved HCM: keep surveillance for recurrence or remodeling. Other apparently resolved disease (arrhythmia, pulmonic stenosis): surveillance as for an adolescent or adult with no known disease.Gripp 2019 Table 1
On GHCardiac evaluation before starting; every 6 mo for the first year, for HCM.Gripp 2019 text
Cardio-facio-cutaneous syndrome

Pierpont 2014, expert conference; not graded.

Age or groupWhat and how oftenSource
At diagnosisEcho and ECG (Table 1). Pediatric cardiologist and echo as soon as CFC is recognized or confirmed (text); Table 1 makes the cardiologist conditional on a murmur or suggestive features.Pierpont 2014 Table 1, text
To 20 yNo cardiac disease: echo every 2–3 y; BP each visit. Infancy to 1 y: 24-h Holter if arrhythmias.Pierpont 2014 Table 1
Adult, >20 yNo previous heart disease: echo every 3–5 y; BP each visit.Pierpont 2014 Table 1
All agesAll, even after normal echoes or repair: periodic re-evaluation by a cardiologist, who sets the frequency when there is cardiac disease.Pierpont 2014 Table 1, text
Turner syndrome

Gravholt 2024 international guideline; GRADE symbols as printed. Aortic Z scores and ASI: Turner Syndrome Aortic Z-Scores

Guidelines differ. Over 15 y, at ASI ≥2.3 cm/m² without risk factors, Gravholt 2024 (the rows below): every 1–2 y. ACC/AHA 2022: ASI >2.3 at least annually. ESC 2024: every year at ASI 23–25 mm/m² (2.3–2.5 cm/m²).

Aortic imaging interval. Suggested algorithm; R 4.13 ⨁○○○. ASI in cm/m², AHI in mm/m. Under 15 y, Figure 4 uses the Turner-specific Z only (R 4.14): ASI does not place a child in this grid. Over 15 y, ASI, AHI and Z can fall in different columns; the figures do not say which governs, and the guideline prefers no index. Rapid dilation and other added risk factors can change the interval.
Age or groupWhat and how oftenSource
<15 yNo BAV, HTN or CoA: Z <3.0, every 3–5 y. Low risk.Adapted from Gravholt 2024 Figure 4
<15 yNo BAV, HTN or CoA: Z ≥3.0, every 1–2 y. Moderate risk.Adapted from Gravholt 2024 Figure 4
<15 yBAV, HTN or CoA: Z <3.0, every 1–2 y. Moderate risk.Adapted from Gravholt 2024 Figure 4
<15 yBAV, HTN or CoA: Z ≥3.0, every 6 mo–1 y. High risk.Adapted from Gravholt 2024 Figure 4
Adult, >15 yNo BAV, HTN or CoA: ASI ≤2.0, AHI ≤20, Z ≤2.5: every 5–10 y. Low risk.Adapted from Gravholt 2024 Figure 5
Adult, >15 yNo BAV, HTN or CoA: 2.0 < ASI < 2.3, 20 < AHI < 23, 2.5 < Z < 3.5: every 2–5 y. Moderate risk.Adapted from Gravholt 2024 Figure 5
Adult, >15 yNo BAV, HTN or CoA: ASI ≥2.3, AHI ≥23, Z ≥3.5: every 1–2 y. Moderate-high risk.Adapted from Gravholt 2024 Figure 5
Adult, >15 yBAV, HTN or CoA: ASI <2.3, AHI <23, Z <3.5: every 1–2 y. Moderate-high risk.Adapted from Gravholt 2024 Figure 5
Adult, >15 yBAV, HTN or CoA: ASI ≥2.3, AHI ≥23, Z ≥3.5: every 6 mo–1 y. High risk.Adapted from Gravholt 2024 Figure 5
Adult, >15 yConsider evaluation for elective repair: ASI >2.5 (AHI >25, Z >4), or ASI >2.3 (AHI >23, Z >3.5) with additional risk factors. Thresholds: Aortopathy.Adapted from Gravholt 2024 Figure 5 caption
Schedule and other tests
Age or groupWhat and how oftenStrengthSource
No CV diseaseTTE at 9–11 y, after growth completion or at transition; adults at least every 5–10 y. Figures 2–3 add a cardiology visit at 4–6 y (ECG, BP, imaging only if needed), deferrable to 9–11 y if a cardiologist reviewed neonatal images, ruled out significant lesions and there are no concerning signs or symptoms; CMR or CT at 15–16 y or after growth.We recommend ⨁⨁○○; figures not gradedGravholt 2024 R 4.8, Figures 2–3
FetalFetal echo if highly suspected or confirmed prenatally.We recommend ⨁⨁⨁○Gravholt 2024 R 4.1
NewbornPrenatal diagnosis or suspicion: TTE at day 2–3, sooner if CHD suspected, even if fetal echo was normal.We recommend ⨁⨁⨁○Gravholt 2024 R 4.4
At diagnosisTTE, all children and adults.We recommend ⨁⨁⨁○Gravholt 2024 R 4.7
At diagnosisResting ECG. Later ECGs at intervals set by baseline findings, CHD and course; calculate QTc (Hodges).We recommend ⨁⨁⨁⨁Gravholt 2024 R 4.24; R 4.25 We suggest ⨁⨁○○
Infant, childNormal heart and aorta, no symptoms: first CMR still recommended; can wait until no general anesthesia is needed.⨁⨁○○Gravholt 2024 R 4.9
Adolescent, adultCMR, with or instead of the first echo, in all newly diagnosed; ideally within 12 mo.⨁⨁○○Gravholt 2024 R 4.10
All agesShow coronary origins and proximal course in all.We recommend ⨁⨁○○Gravholt 2024 R 4.6
All agesBP yearly, preferably ambulatory monitoring.We recommend ⨁⨁○○Gravholt 2024 R 4.17
Screening ageLipid profile no later than the country’s screening age or at transition, then every 3 y.We recommend ⨁⨁○○Gravholt 2024 R 4.22
PregnancyBefore planned pregnancy or assisted reproduction: imaging, ideally CMR or CT, within 2 y. Low-risk pregnancy: TTE at least once, ideally around 20 weeks.We recommend ⨁⨁○○Gravholt 2024 R 4.32, R 4.36
PregnancyWith aortic dilation or another risk factor: TTE at least every 12 weeks.We suggest ⨁○○○Gravholt 2024 R 4.37
Marfan syndrome

Surveillance by age: Aortopathy, Marfan.

Loeys-Dietz syndrome

Surveillance, including head-to-pelvis imaging: Aortopathy, Loeys-Dietz.

Vascular Ehlers-Danlos syndrome

Aortic and peripheral arterial surveillance: Aortopathy, vascular EDS.

Holt-Oram syndrome

AHA 2018 statement; not graded; no syndrome-specific guideline found.

Age or groupWhat and how oftenSource
All agesECG yearly, all individuals, for conduction disease with or without CHD.AHA 2018, Holt-Oram, Cardiac Features
Jacobsen syndrome (11q deletion)

AHA 2018 statement; not graded.

Age or groupWhat and how oftenSource
BaselineCardiac evaluation with echo at baseline and as needed. No interval stated.AHA 2018, General Clinical Recommendations
Tuberous sclerosis complex

Northrup 2021 international consensus; NCCN categories as printed; statements with no mark are Category 3.

Age or groupWhat and how oftenStrengthSource
FetalRhabdomyomas on prenatal ultrasound: consider fetal echo, to detect high risk of heart failure after delivery.Category 1, printed at end of paragraphNorthrup 2021 Table 3, text
Child, at diagnosisEcho, especially below 3 y, and 12- to 15-lead ECG.Category 1, printed at end of paragraphNorthrup 2021 Table 3, text
Adult, at diagnosisBaseline ECG. Echo not necessary without cardiac symptoms or a concerning medical history.Category 2ANorthrup 2021 Table 3, text
ChildAsymptomatic: echo every 1–3 y until rhabdomyoma regression is documented.Category 1, printed at end of paragraphNorthrup 2021 Table 4, text
All agesAsymptomatic: 12-lead ECG at least every 3–5 y for conduction defects. Symptoms, additional risk factors or significant abnormalities: more often, may include ambulatory event monitoring.Category 1, printed at end of paragraphNorthrup 2021 Table 4, text
Arrhythmia riskKnown arrhythmia or a high-risk ECG: tell the patient some medications and supplements can raise the risk; check with the cardiologist or TSC specialist before starting one.Category 3 (no mark printed)Northrup 2021 text
Neurofibromatosis type 1

AAP 2019 clinical report; not graded. AAP reports expire at 5 years unless reaffirmed (2024 here); no reaffirmation found.

Age or groupWhat and how oftenSource
Newborn, infantCardiac examination, for congenital malformations such as pulmonic stenosis; cardiology referral or echo based on the examination.AAP 2019 Table 4, Vascular
ChildrenMurmur or NF1 microdeletion: cardiology examination and echo. Whether to screen all with echo is unclear; those with a large deletion should be evaluated.AAP 2019, Vascular
ChildrenBP at least yearly (Table 4 lists it from 1–5 y; more often as indicated).AAP 2019 Table 4, Vascular
Persistent HTNAssess large vessels, including renal arteries: Doppler ultrasonography of the aorta and renal arteries, renal arteriography or MRA.AAP 2019, Vascular
Acute, dramatic HR or BP riseMost experts recommend screening for pheochromocytoma; rare in children.AAP 2019, Malignancies
PHACE syndrome

Garzon 2016, consensus-derived; not graded.

Age or groupWhat and how oftenSource
At-risk childScreening echo and MRI with MRA of head, neck and aortic arch at baseline.Garzon 2016, screening recommendations
Abnormal echoIntracardiac or arch anomaly: urgent pediatric cardiology; cardiac MRI/MRA if arch abnormality suspected.Garzon 2016, Echocardiogram
ChildrenNonobstructive arch anomaly: pediatric cardiology with yearly echo.Garzon 2016, Echocardiogram
Cornelia de Lange syndrome

Kline 2018 first international consensus; the level of R10 is in a supplement, not read.

Age or groupWhat and how oftenSource
Infant, childRoutine echo in every diagnosed infant and child; in adolescents, guided by symptoms. No interval stated.Kline 2018, Paediatric medical follow-up
Rubinstein-Taybi syndrome

Lacombe 2024 first international consensus; the grade is in a supplement, not read.

Age or groupWhat and how oftenSource
At diagnosisCardiovascular evaluation including cardiac sonography. No interval stated.Lacombe 2024, Cardiovascular system

What guidelines and society statements recommend, at what age and how often; adult rows labelled

Key points

Sources and how this page was checked

Full text read

Abstract only, not read or not used

Left out

How it was checked